DYNAMIC chromatin regulation is key to the adaptive mechanisms eukaryotic cells employ to alter cellular phenotype in response to fluctuating environmental conditions, such as changes in nutrient availability and various forms of stress. Environmental regulation of the epigenome profoundly affects health and disease, but how the chromatin regulatory apparatus responds to such influences is not understood ([@bib37]; [@bib56]). A universally conserved signaling pathway regulated by the environment is the target of rapamycin (TOR) pathway ([@bib35]; [@bib33]). TOR consists of two distinct subpathways involving TOR complex 1 (TORC1) and TOR complex 2 (TORC2), of which only TORC1 is activated by environmental inputs ([@bib35]; [@bib33]). In single-celled organisms such as budding yeast, TORC1 is specifically stimulated by the quantity and quality of the available nitrogen source; however, while controversial, recent studies also have suggested potential crosstalk between glucose signaling, carbon metabolism, and TORC1 activation ([@bib51]; [@bib54]; [@bib44]; [@bib9]). Metazoan TORC1 is also regulated by nutrients, specifically amino acids, but requires an additional mitogen/growth factor input for its activation ([@bib33]). TORC1 signaling regulates anabolic processes, including the transcription of genes required for ribosome biogenesis, control of translation, and suppression of catabolic stress responses such as autophagy ([@bib35]; [@bib33]). Given the role TORC1 has in responding to nutrient availability and environmental stress, it is ideally positioned to facilitate information transfer from the environment to the epigenetic regulatory machinery.

Yeast TORC1 consists of either the [Tor1](http://www.yeastgenome.org/locus/S000003827/overview) or [Tor2](http://www.yeastgenome.org/locus/S000001686/overview) kinase, [Kog1](http://www.yeastgenome.org/locus/S000001229/overview), [Lst8](http://www.yeastgenome.org/locus/S000004951/overview), and the nonessential subunit [Tco89](http://www.yeastgenome.org/locus/S000006101/overview) ([@bib36]; [@bib45]). Loss of either [Tor1](http://www.yeastgenome.org/locus/S000003827/overview) or [Tco89](http://www.yeastgenome.org/locus/S000006101/overview) causes hypersensitivity to conditions that suppress TORC1 signaling, including nutrient deprivation and the naturally occurring TORC1 inhibitor rapamycin ([@bib35]). In yeast, TORC1 resides predominantly on the vacuole's surface where it is activated by luminal amino acid accumulation ([@bib2]; [@bib9]). Active TORC1 then signals through at least two well-defined downstream effector pathways. The best characterized is the AGC kinase [Sch9](http://www.yeastgenome.org/locus/S000001248/overview), which is directly phosphorylated and activated by TORC1 ([@bib59]). Active [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) can then phosphorylate a number of distinct substrates, many of which function directly in ribosomal gene transcription and protein translation ([@bib59]; [@bib24]; [@bib25]). A recent study identified the existence of a TORC1 effector pathway distinct from [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) involving the [Ypk3](http://www.yeastgenome.org/locus/S000000232/overview) kinase, which phosphorylates ribosomal S6, yet this pathway still remains poorly characterized ([@bib16]).

In the presence of a high-quality nitrogen source, TORC1 also phosphorylates the essential factor [Tap42](http://www.yeastgenome.org/locus/S000004630/overview) ([@bib11]; [@bib30]; [@bib63]). Phosphorylated [Tap42](http://www.yeastgenome.org/locus/S000004630/overview) interacts with the evolutionarily conserved protein phosphatase 2A (PP2A) and PP2A-like phosphatases, which sequesters these enzymes onto the vacuolar surface and restricts their access to client substrates ([@bib11]; [@bib30]; [@bib63]). Upon nitrogen starvation and reduction of vacuolar amino acids, [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-regulated phosphatase complexes are released that then dephosphorylate several key transcription factors, including [Gln3](http://www.yeastgenome.org/locus/S000000842/overview) and [Gat1](http://www.yeastgenome.org/locus/S000001873/overview) ([@bib1]; [@bib32]; [@bib7]). Dephosphorylation triggers [Gln3](http://www.yeastgenome.org/locus/S000000842/overview) and [Gat1](http://www.yeastgenome.org/locus/S000001873/overview) dissociation from their cytoplasmic anchor [Ure2](http://www.yeastgenome.org/locus/S000005173/overview) and their subsequent nuclear translocation. Nuclear [Gln3](http://www.yeastgenome.org/locus/S000000842/overview) and [Gat1](http://www.yeastgenome.org/locus/S000001873/overview) then regulate transcription of genes involved in the metabolism of nonpreferred nitrogen sources as part of the nitrogen catabolite repression (NCR) response ([@bib6]). Each of the [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-regulated phosphatases consists of a defining catalytic subunit, as well as additional regulatory subunits that elicit distinct regulatory functions. For example, the catalytic subunit of the PP6 phosphatase complex, [Sit4](http://www.yeastgenome.org/locus/S000002205/overview), forms heterodimers with one of four regulatory subunits ([Sap4](http://www.yeastgenome.org/locus/S000003198/overview), [Sap155](http://www.yeastgenome.org/locus/S000001936/overview), [Sap185](http://www.yeastgenome.org/locus/S000003634/overview), or [Sap190](http://www.yeastgenome.org/locus/S000001736/overview)) that direct its enzymatic activity to specific substrates involved in cell-cycle regulation, transcription, and translation ([@bib38]; [@bib47]).

Recently, TORC1 has also been implicated in the regulation of chromatin structure through control of histone post-translational modifications. For example, TORC1-dependent transcription of ribosomal protein gene expression was demonstrated to require the [Esa1](http://www.yeastgenome.org/locus/S000005770/overview) histone acetyltransferase, which acetylates histone H4 ([@bib46]). TORC1 suppression was also shown to cause rapid histone deacetylation of ribosomal DNA (rDNA) repeats and increased transcriptional silencing via recruitment of the sirtuin deacetylase [Sir2](http://www.yeastgenome.org/locus/S000002200/overview) ([@bib18]). Our group recently demonstrated that TORC1 regulates global histone H3 lysine 56 acetylation (H3K56ac) to facilitate ribosomal RNA synthesis by RNA polymerase I through a pathway connected to the sirtuins [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) and [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) ([@bib5]). However, the relationship between TORC1 signaling and these sirtuins was not defined in detail. A subsequent study demonstrated that TORC1 signaling causes rDNA repeat expansion, while decreased TORC1 activity reduces rDNA repeat number through a mechanism requiring [Sir2](http://www.yeastgenome.org/locus/S000002200/overview), [Hst3](http://www.yeastgenome.org/locus/S000005551/overview), and [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) ([@bib28]). Sirtuin deacetylases are a family of class III NAD^+^-dependent deacetylases whose catalytic activities are inversely regulated by energy state ([@bib27]). Interestingly, in metazoans, TORC1 signaling and sirtuin activity also are regulated in an opposing fashion ([@bib15]; [@bib17]; [@bib8]). Therefore, these studies suggest that TORC1 signaling and sirtuin activity may be coordinated in opposing ways to link control of epigenetic changes needed for anabolism with the availability of environmental nutrients to support these processes.

In this report, we expand on these concepts to demonstrate that nitrogen availability signals through TORC1 to regulate site-specific acetylation of select histone H3 and H4 N-terminal lysine residues besides H3K56ac. We demonstrate that TORC1 controls these modifications globally via repression of [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-regulated [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) phosphatase activity. TORC1 suppression promotes a decrease in histone acetylation, which requires the activation of [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) and the sirtuins [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) and [Hst4](http://www.yeastgenome.org/locus/S000002599/overview). Specifically in the case of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview), reduced TORC1 activity increases [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) nuclear localization and reduces [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein turnover, suggesting that [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) nuclear localization may stabilize the enzyme to mediate histone deacetylation under nutrient-limiting conditions. This TORC1-dependent suppression of [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)/PP6 and downstream negative regulation of sirtuins is biologically relevant as deletions of [Sit4](http://www.yeastgenome.org/locus/S000002205/overview), [Hst3](http://www.yeastgenome.org/locus/S000005551/overview), or [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) rescue some TORC1 mutant phenotypes.

Materials and Methods {#s1}
=====================

Yeast plasmids, strains, and culture conditions {#s2}
-----------------------------------------------

The strains and plasmids utilized are listed in Supplemental Material, [Table S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/TableS1.pdf) and [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/TableS2.pdf), respectively. Gene deletion and epitope tagging procedures were conducted as described previously ([@bib29]). Unless explicitly stated, all yeast cultures and plating assays were performed in 1% yeast extract/2% peptone/2% dextrose (YPD). Yeast drop-out synthetic complete (SC) media were prepared as described previously ([@bib34]). All yeast culture media were purchased from US Biologicals and Research Products International, and antibiotics for selection were obtained from Invitrogen (Carlsbad, CA) or GoldBio. Cells were cultured either at 30° or room temperature (for the *tap42ts* experiments) with shaking. For the spotting assays, equal cell numbers from overnight cultures were pelleted, washed, and serially diluted fivefold. Cells were then spotted to the appropriate plates, incubated at the indicated temperatures, and photographed daily. Full-length *[TCO89](http://www.yeastgenome.org/locus/S000006101/overview)* or *[SIT4](http://www.yeastgenome.org/locus/S000002205/overview)* open reading frames were cloned in-frame as C-terminal mono-FLAG fusions into the *Bam*HI/*Xba*I (*[TCO89](http://www.yeastgenome.org/locus/S000006101/overview)-FLAG*) or *Bam*HI/*Eco*RI (*[SIT4](http://www.yeastgenome.org/locus/S000002205/overview)-FLAG*) restriction sites of plasmid p416ADH, which contains an *[ADH1](http://www.yeastgenome.org/locus/S000005446/overview)* promoter and *[CYC1](http://www.yeastgenome.org/locus/S000003809/overview)* terminator sequence ([@bib42]).

Stains and antibodies {#s3}
---------------------

The antibodies used are as follows: α-RPS6 (Abcam), α-phosphoS6 (Cell Signaling), α-FLAG (Stratagene, La Jolla, CA), goat α-rabbit HRP-conjugated secondary (The Jackson Laboratory), α-HA and α-Myc A14 (Santa Cruz Biotechnology), α-G6PDH (Sigma, St. Louis, MI), α-FLAG (ThermoFisher), and goat α-rabbit FITC-conjugated secondary (Rockland). All histone antibodies were purchased from Active Motif. For confocal microscopy, Vectashield mounting media containing DAPI were purchased from Vector Laboratories (Burlingame, CA).

RT-quantitative PCR, statistical analyses, and immunoblot analyses {#s4}
------------------------------------------------------------------

Total RNA was extracted and 1 μg of DNase I digested RNA was used to synthesize randomly primed complementary DNA (cDNA) using the ImProm II reverse transcription system from Promega (Madison, WI). Gene-specific quantitative PCR (qPCR) with normalization to the *[SPT15](http://www.yeastgenome.org/locus/S000000950/overview)* housekeeping gene was performed and analyzed as previously described ([@bib34]). Primer sequences are available upon request. All statistical analyses reported in this study were performed using Student's *t*-test and the statistical suite available in Microsoft Excel. Whole-cell extracts were prepared and immunoblotting was performed as outlined previously ([@bib34]). To quantify histone immunoblot results, films were scanned and analyzed by ImageJ software. Histone acetylation states were always normalized to total histone H3 levels to account for any variability in histone levels.

Indirect immunofluorescence confocal microscopy {#s5}
-----------------------------------------------

Small scale cultures (10 ml) were cultured to log phase and treated as indicated. The cells were then fixed with 37% formaldehyde, pelleted, and washed twice with 0.1 M potassium phosphate buffer (K~2~HPO~4~, pH = 6.5) and once with 4 ml P solution (1.2 M sorbitol, 0.1 M K~2~HPO~4~, pH = 6.5). Pellets were resuspended in 1 ml P solution, 15 μl LongLife Zymolase (15 mg/ml in P solution) and 5 μl β-mercaptoethanol, followed by a 25-min incubation with gentle mixing at room temperature. After zymolase treatment, cells were pelleted, resuspended in 150 μl of P solution, and distributed evenly across two hydrophobic barrier regions of a polylysine-coated microscope slide. Cells were allowed to settle prior to blocking (8% bovine serum albumin, 0.5% Tween 20 in PBS for 20 min). Blocking solution was removed and primary antibody (1:100 α-Myc) was added for a humidified incubation overnight at 4°. Slides were washed four times with blocking solution and then incubated with FITC-conjugated secondary antibody (1:100) for 60 min at room temperature. The slide washes were repeated four times with blocking solution, twice with PBS, and then a drop of DAPI-containing Vectashield mounting medium was added before coverslip addition and sealing.

Image analysis in Zen 2 Blue {#s6}
----------------------------

Image quantification was performed using Zen 2 Blue Lite, version 2.0.0 software. Two borders were traced onto the image using the Spline Contour tool, one around the cell periphery and the other around the nucleus. After closing each border, values were obtained for the area encompassed by the border, as well as the mean intensity value for each channel inside that space. The area within the nuclear border was multiplied by the mean intensity value for the green channel (FITC-conjugated secondary fluorescence green). This gave a number for the total nuclear fluorescence intensity (TNFI):$$\text{TNFI} = \text{nuclear}~\text{area}\left( \text{nm}^{2} \right) \times {\text{nuclear}~\text{mean}~\text{intensity}~\text{value}}^{7}.$$This same calculation was repeated using the outer cell border values, providing us a measure of the total cellular fluorescence intensity (TCFI):$$\text{TCFI} = \text{cellular}~\text{area}\left( \text{nm}^{2} \right) \times \text{cellular}~\text{mean}~\text{intensity}~\text{value}.$$We then performed the following calculation to get the percentage of nuclear protein:$$\%\text{nuclear} = \text{TNFI}/\text{TCFI} \times 100.$$Cells were chosen for analysis at random, with ∼20--40 quantified per condition, per biological replicate (four to six replicates). Only cells with clear nuclear DNA staining and detectable α-Myc signal were quantified. For the immunostaining, cells whose cellular mean intensity was \<50 units were considered to have not been penetrated by secondary antibody and were excluded from calculations.

Protein turnover analysis {#s7}
-------------------------

Myc-tagged [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) or [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) strains were cultured to log phase in 200 ml YPD media. The 50-ml samples were sterilely retrieved from each flask prior to cycloheximide (CHX) addition (100 μg/ml). Following treatment, additional 50-ml aliquots were taken at the time points indicated. Whole-cell extracts were prepped and analyzed by SDS/PAGE and α-Myc immunoblot. Films were scanned and [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) or [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) levels were normalized to total protein (G6PDH) levels by ImageJ analysis.

Data availability {#s8}
-----------------

The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article.

Results {#s9}
=======

Metabolic signaling through TORC1 regulates site-specific histone H3 and H4 acetylation {#s10}
---------------------------------------------------------------------------------------

Previously, we demonstrated that TORC1 signaling regulates global H3K56ac ([@bib5]). We wanted to assess whether this effect was unique for H3K56ac, or if TORC1 also contributed to the regulation of other histone H3 and H4 acetyl modifications as well. To explore this possibility, we performed immunoblot analysis for site-specific histone H3/H4 N-terminal acetylation modifications. Duplicate wild-type (WT) cultures, as well as a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* (nonessential TORC1 subunit), were cultured to log phase and either mock treated or treated with 300 nM rapamycin for 60 min before preparing whole-cell extracts. The concentration and length of rapamycin treatment chosen was confirmed to inhibit TORC1 signaling via phosphoS6 analysis ([Figure S1A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS1.pdf)). Immunoblot analysis identified H3K18ac, H3K23ac, and H4K12ac to be selectively decreased after TORC1 inhibition, whereas all other acetylation states were unaffected ([Figure 1, A and B](#fig1){ref-type="fig"}). Furthermore, this effect was not due to globally reduced transcription-coupled histone modifications, as histone H3 lysine 4 trimethylation (H3K4me3), which demarcates transcriptionally active genes, was unaffected ([Figure 1A](#fig1){ref-type="fig"}). These changes occurred rapidly as WT cells treated with 200 nM rapamycin for 20 min displayed profoundly reduced global H3K18ac ([Figure S1B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS1.pdf)). Importantly, restoration of WT [Tco89](http://www.yeastgenome.org/locus/S000006101/overview) expression in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells completely rescued histone acetylation, thereby demonstrating that the reduced acetylation were solely due to impaired TORC1 activity ([Figure 1C](#fig1){ref-type="fig"}).

![Nitrogen signaling through TORC1 regulates site-specific histone acetylation. (A) WT and *tco89Δ* strains were cultured to log phase and WT cells were then mock treated or treated with 300 nM rapamycin for 1 hr before harvesting. Whole-cell extracts were then analyzed by immunoblot (IB) with the indicated antibodies. α-H3 is included as the loading control for the panel. (B) Quantification of the results from A. Data are the average and SD of a minimum of four or more independent experiments and significance was determined by Student's *t*-test. \* *P* \< 0.05; \*\* *P* \< 0.01; \*\*\* *P* \< 0.001. (C) WT and *tco89Δ* were transformed with control vector or a *TCO89-9xMyc* expression vector. Log phase cells were harvested and analyzed by IB with the indicated antibodies. (D) WT and *tco89Δ* cells were cultured to log phase in YPD (2% glucose) or YPGly (2% glycerol) before preparing cell extracts and IB analysis. (E) WT cells were cultured to log phase and then mock treated or treated with 2 mM MSX for 20 min before harvesting and analyzing H3K18ac and phosphoS6 by IB. (F) Quantification of acetylation results from E. Data are the average and SD of nine independent experiments. Significance was determined as in B.](1733fig1){#fig1}

Nitrogen metabolism and amino acid availability are known activators of TORC1 ([@bib1]; [@bib4]; [@bib19]; [@bib7]). Intriguingly, carbon metabolism has also recently been suggested to activate TORC1 through the vacuolar localized V-ATPase complex, while glycolysis is known to control global levels of many of the same histone acetylation sites we have identified to be regulated by TORC1 ([@bib14]; [@bib9]). Therefore, we next determined the impact these distinct nutrient signals have on TORC1-regulated acetylation. Changing the carbon source from glucose to a nonfermentable carbon (glycerol) failed to decrease histone acetylation in WT cells, nor did it suppress the acetylation defect observed in the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* mutant ([Figure 1D](#fig1){ref-type="fig"}). Because cells grow considerably slower in the presence of a nonfermentable carbon, these results also exclude the possibility that the difference in acetylation between WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* is caused by a reduced growth rate in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ*. To assess the contribution of nitrogen metabolism, we cultured WT cells to log phase and mock treated or treated cells for 20 min with 2 mM L-methionine sulfoximine (MSX) to inhibit glutamine synthetase, thus mimicking a nitrogen starvation state. MSX rapidly decreased H3K18ac ([Figure 1E](#fig1){ref-type="fig"}, top panel, and [F](#fig1){ref-type="fig"}), which we confirmed also suppressed TORC1 activity ([Figure 1E](#fig1){ref-type="fig"}, bottom panel). These data demonstrate that nitrogen-, but not carbon-dependent TORC1 activation is responsible for regulating these site-specific histone acetylation states.

TORC1 signaling through the Tap42-Sit4/PP6 phosphatase is required for global site-specific histone acetylation {#s11}
---------------------------------------------------------------------------------------------------------------

TORC1 activates multiple downstream effectors, including the [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) kinase, which is directly phosphorylated by TORC1 ([@bib59]). To determine if TORC1 regulates histone acetylation through [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) activation, we utilized a series of previously described [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) plasmids including [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^WT^, [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^5A^, in which the TORC1 target sites are mutated to alanine to mimic the nonphosphorylated form, and [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^2D3E^, in which the TORC1 target sites are mutated to acidic residues, rendering it active independent of TORC1 ([@bib59]). Critically, we found that these various mutant forms had similar expression and stability ([Figure S2A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS2.pdf)). Additionally, we confirmed that in *[sch9](http://www.yeastgenome.org/locus/S000001248/overview)Δ*, the [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^2D3E^ plasmid promoted growth on nonfermentable carbon and rapamycin as expected ([Figure S2B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS2.pdf)) ([@bib59]). We also confirmed that in a *[sch9](http://www.yeastgenome.org/locus/S000001248/overview)Δ*+pSch9^2D3E^ strain, [Maf1](http://www.yeastgenome.org/locus/S000002412/overview) phosphorylation (a direct substrate of [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)) was maintained after rapamycin inhibition ([Figure S2C](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS2.pdf)) ([@bib24]; [@bib61]), all together demonstrating that [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^2D3E^ functioned as expected. However, *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells expressing [Sch9](http://www.yeastgenome.org/locus/S000001248/overview)^2D3E^ failed to rescue histone acetylation ([Figure 2A](#fig2){ref-type="fig"}). Similarly, a *[sch9](http://www.yeastgenome.org/locus/S000001248/overview)Δ* strain did not reduce histone acetylation ([Figure 2B](#fig2){ref-type="fig"}), thus demonstrating that TORC1-dependent acetylation is regulated independently of [Sch9](http://www.yeastgenome.org/locus/S000001248/overview).

![Tap42, not Sch9, is the TORC1 downstream effector promoting changes in histone acetylation states. (A) WT and *tco89Δ* cells were transformed with control vector or an SCH9^2D3E^-HA expression vector and cultured to log phase before harvesting and analyzing acetylation by IB and ImageJ as indicated. An α-HA blot is included as control for Sch9^2D3E^ expression. Data are representative of at least three independent replicates, and mean histone acetylation values (relative to H3 with WT set to 1) are provided below the corresponding panel. (B) WT, *tco89Δ,* and *sch9Δ* cells were cultured to log phase before harvest. Four independent sets of extracts were analyzed by IB and ImageJ as described in A. (C) *tap42Δ* mutants expressing plasmid-borne *TAP42* or the indicated *tap42ts* mutants were cultured overnight to saturation. Equal numbers of cells were serially diluted fivefold, spotted onto YPD plates, and incubated either at room temperature (permissive), 30° (semipermissive), or 33° (nonpermissive) for 2 days before photographing. (D) *TAP42* WT and *tap42-106ts* strains were cultured to log phase at room temperature before heat shocking at 30° for 1 hr. Cells were then harvested and analyzed with the indicated antibodies. (E) Quantification of results from D. Data in E are the average and SD of three independent experiments and significance was determined by Student's *t*-test. \* *P* \< 0.05; \*\* *P* \< 0.01; \*\*\* *P* \< 0.001.](1733fig2){#fig2}

Next, we asked whether TORC1 signaled through its other downstream effector, [Tap42](http://www.yeastgenome.org/locus/S000004630/overview), to regulate histone acetylation. *[TAP42](http://www.yeastgenome.org/locus/S000004630/overview)* is an essential gene, so we utilized *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)Δ* cells containing a plasmid expressing either WT or temperature-sensitive (*ts*) *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)* alleles ([@bib64]). We confirmed the temperature sensitivity of these strains and chose *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)-106* for further analysis because it exhibited the least growth inhibition at 30° ([Figure 2C](#fig2){ref-type="fig"}). As a consequence, it would be less likely to have nonspecific effects on acetylation due to loss of viability. WT and *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)-106* cells were cultured to log phase at permissive (25°) temperature before being shifted to 30° for 1 hr. Even at room temperature, where there is no evident growth phenotype ([Figure 2C](#fig2){ref-type="fig"}), the *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)-106* mutant exhibited significant H3K18ac reduction, thus implicating [Tap42](http://www.yeastgenome.org/locus/S000004630/overview) in histone acetylation regulation ([Figure 2, D and E](#fig2){ref-type="fig"}). Importantly, the decreased acetylation was specific for H3K18ac, as H3K9ac, which is not affected by TORC1 inhibition, was intact ([Figure 1A](#fig1){ref-type="fig"} and [Figure 2D](#fig2){ref-type="fig"}). At the more restrictive (30°) temperature, *[tap42](http://www.yeastgenome.org/locus/S000004630/overview)-106* caused an even greater reduction in H3K18ac without affecting H3K9ac ([Figure 2, D and E](#fig2){ref-type="fig"}). Taken together, these results demonstrate that TORC1 signals through a [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-dependent phosphatase pathway to regulate site-specific histone acetylation.

TORC1-dependent [Tap42](http://www.yeastgenome.org/locus/S000004630/overview) phosphorylation allows [Tap42](http://www.yeastgenome.org/locus/S000004630/overview) to interact with PP2A and PP2A-like phosphatase (PP'ase) complexes, which promotes their sequestration to the vacuole surface and restricts their access to substrates ([@bib11]; [@bib30]; [@bib63]). To identify which candidate PP'ase is required for TORC1-regulated acetylation, we screened deletion mutants of individual catalytic PP'ase subunits ([PPG1](http://www.yeastgenome.org/locus/S000005315/overview)/*[ppg1](http://www.yeastgenome.org/locus/S000005315/overview)Δ*, PP4/*[pph3](http://www.yeastgenome.org/locus/S000002482/overview)Δ*, and PP6/*[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ*) for the loss of rapamycin-induced deacetylation. Since two redundant catalytic subunits exist for PP2A ([Pph21](http://www.yeastgenome.org/locus/S000002292/overview) and [Pph22](http://www.yeastgenome.org/locus/S000002347/overview)), we instead examined a *[tpd3](http://www.yeastgenome.org/locus/S000000014/overview)Δ*, which eliminates the PP2A regulatory subunit and impairs PP2A activity ([@bib22]). TORC1 inhibition suppressed H3K18ac, as well as H3K56ac, which we previously identified to be TORC1 dependent, in WT cells and all mutants examined except for *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* ([Figure 3A](#fig3){ref-type="fig"} and data not shown).

![The Tap42--Sit4 PP6 phosphatase complex is necessary for TORC1-dependent chromatin changes. (A) WT and the indicated PP'ase mutants were cultured to log phase and then mock or 300 nM rapamycin treated for 1 hr before harvesting and performing IB and ImageJ analysis with the indicated antibodies. (B) WT and *sit4Δ* cells were transformed with control vector or a *SIT4-FLAG* expression vector and the rapamycin experiment from A was repeated. Both a short and long exposure of the H3K18ac IBs are provided for clarity. (C) WT, *sit4Δ*, *tco89Δ*, and *tco89Δ sit4Δ* cells were cultured to log phase before preparing cell extracts and analyzing by IB as in A. (D) As in A except individual deletions of the Sap-encoding genes were probed. (E) WT, *tco89Δ*, *ure2Δ*, *sit4Δ*, *gln3Δ*, and *gat1Δ* cells were cultured to log phase and whole-cell extracts were analyzed by IB and ImageJ with the indicated antibodies. Blots and mean acetylation data relative to H3 (mock set to 1) presented in A--E are representative of at least four independent experiments.](1733fig3){#fig3}

To confirm the [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-catalyzed PP6 phosphatase complex was indeed responsible for TORC1-dependent acetylation, WT and *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* cells were reconstituted with control vector or a vector expressing a [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)--FLAG construct. In control vector containing *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* cells, higher basal H3K18ac levels were detected that were insensitive to rapamycin, while *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* expressing WT [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) reduced H3K18ac and restored rapamycin-dependent acetylation repression ([Figure 3B](#fig3){ref-type="fig"}). We also confirmed that *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* alone increased basal H3K18ac while a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* restored H3K18 acetylation to near WT levels relative to *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* ([Figure 3C](#fig3){ref-type="fig"}). These results suggest that [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) mediates active repression of histone acetylation under limited TORC1 signaling conditions. As [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) partners with one of four different Sap ([Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-associated protein) regulatory subunits to target distinct substrates, we utilized the same approach from [Figure 3A](#fig3){ref-type="fig"} to evaluate the contributions of these ancillary subunits to acetylation regulation. Interestingly, we determined that no single SAP deletion is sufficient to restore WT H3K18 acetylation (compare to the effect of *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* in [Figure 3A](#fig3){ref-type="fig"}), although the most significant rescue is observed in the *[sap4](http://www.yeastgenome.org/locus/S000003198/overview)Δ* and *[sap185](http://www.yeastgenome.org/locus/S000003634/overview)Δ* strains ([Figure 3D](#fig3){ref-type="fig"}). This suggests the possibility that these Saps have some functional redundancy as has been suggested previously ([@bib47]).

The best characterized [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) function is in the regulation of the NCR response ([@bib1]; [@bib7]). Because nitrogen signaling through TORC1 regulates histone acetylation in a [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-dependent fashion, we probed whether [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) mediated this effect through activation of the NCR gene expression program. Surprisingly, while [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) loss significantly upregulated basal H3K18ac levels as expected, we determined that neither deletion of the transcription factors [Gln3](http://www.yeastgenome.org/locus/S000000842/overview) and [Gat1](http://www.yeastgenome.org/locus/S000001873/overview), nor their cytoplasmic anchor [Ure2](http://www.yeastgenome.org/locus/S000005173/overview), resulted in a similar increase in acetylation ([Figure 3E](#fig3){ref-type="fig"}). These findings demonstrate that while the [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-catalyzed PP6 phosphatase complex specifically represses acetylation under TORC1 limiting conditions, it does so independently of the NCR pathway.

TORC1 opposes sirtuin deacetylase function to promote histone acetylation in a site-specific fashion {#s12}
----------------------------------------------------------------------------------------------------

We next tested whether TORC1-dependent acetylation involved sirtuin deacetylases since we previously identified a connection between TORC1 and sirtuins in H3K56ac regulation ([@bib5]). Initially, we cultured WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells to log phase and either mock treated or treated with the pan-sirtuin inhibitor nicotinamide before analyzing acetylation. Basal H3K18ac increased in nicotinamide-treated WT cells, suggesting a role for sirtuins in regulating global steady-state acetylation levels, while nicotinamide completely restored acetylation in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* ([Figure 4A](#fig4){ref-type="fig"}). Additionally, treating log phase WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cultures with the inhibitor FK866, which inhibits nicotinamide phosphoribosyltransferase to suppress NAD^+^ biosynthesis and inactivate sirtuins, completely restored acetylation in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* ([Figure 4B](#fig4){ref-type="fig"}) ([@bib20]). TORC1 actively suppresses transcription of the *[PNC1](http://www.yeastgenome.org/locus/S000003005/overview)* gene, which encodes a nicotinamidase that degrades nicotinamide to nicotinic acid as part of the NAD^+^ salvage pathway ([@bib41]). Therefore, one possible link between TORC1 suppression and reduced histone acetylation could be increased [Pnc1](http://www.yeastgenome.org/locus/S000003005/overview) enzymatic activity, which would reduce nicotinamide levels to consequently activate sirtuins. Surprisingly, combining *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* with a *[pnc1](http://www.yeastgenome.org/locus/S000003005/overview)Δ* failed to restore histone acetylation, demonstrating that TORC1 suppression does not reduce histone acetylation by upregulating *[PNC1](http://www.yeastgenome.org/locus/S000003005/overview)* gene expression ([Figure 4C](#fig4){ref-type="fig"}). Collectively, these results demonstrate that TORC1 suppression reduces histone acetylation through a [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) and sirtuin-dependent pathway, but it does so independently of changes to the NAD^+^ biosynthetic pathway known to activate sirtuins.

![TORC1-responsive histone acetylation is specifically modulated by the sirtuin histone deacetylases in a site-dependent fashion. (A) WT and *tco89Δ* cells were cultured to log phase and then mock or 25 mM nicotinamide treated for 1 hr before harvesting and IB and ImageJ analysis. Relative acetylation values are provided. (B) WT and *tco89Δ* cells were cultured to log phase and mock treated or treated with 500 nM FK866 for 45 min before preparing extracts and analyzing as in A. (C) WT, *tco89Δ*, *pnc1Δ*, *and tco89Δ pnc1Δ* cells were cultured to log phase and whole-cell extracts were analyzed by IB and ImageJ with the indicated antibodies. (D) WT, *rpd3Δ*, *hda1Δ*, *tco89Δ*, *tco89Δ rpd3Δ*, and *tco89Δ hda1Δ* cells were cultured and analyzed as in C. For data presented in A--D, blots and acetylation values (normalized to H3, WT set to 1) are representative of at least three independent replicates. (E) Histone acetylation IB analysis of WT, *tco89Δ*, or *tco89Δ* combined with the indicated sirtuin deletions. (F) Quantification of E. Data in F are the average and SD of four or more independent experiments with significance determined by Student's *t*-test. *\* P* \< 0.05; *\*\* P* \< 0.01; *\*\*\* P* \< 0.001.](1733fig4){#fig4}

To test whether the decrease in acetylation downstream of TORC1 inhibition might additionally involve class I and II histone deacetylases, we combined *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* with a deletion in either the major class I or class II deacetylase (*[rpd3](http://www.yeastgenome.org/locus/S000005274/overview)Δ* and *[hda1](http://www.yeastgenome.org/locus/S000004966/overview)Δ*, respectively) known to regulate transcription and then analyzed whether inactivating either of these enzymes restored histone acetylation ([@bib48]). Although basal acetylation was increased at our TORC1-responsive sites (K18ac and K23ac) in both the *[rpd3](http://www.yeastgenome.org/locus/S000005274/overview)Δ* and *[hda1](http://www.yeastgenome.org/locus/S000004966/overview)Δ* cells, the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [rpd3](http://www.yeastgenome.org/locus/S000005274/overview)Δ* and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hda1](http://www.yeastgenome.org/locus/S000004966/overview)Δ* still displayed diminished acetylation, thus confirming that TORC1 acts independently of major class I or class II deacetylases to control global histone acetylation states ([Figure 4D](#fig4){ref-type="fig"}). Five sirtuins ([Hst1](http://www.yeastgenome.org/locus/S000005429/overview), [Hst2](http://www.yeastgenome.org/locus/S000005936/overview), [Hst3](http://www.yeastgenome.org/locus/S000005551/overview), [Hst4](http://www.yeastgenome.org/locus/S000002599/overview), and [Sir2](http://www.yeastgenome.org/locus/S000002200/overview)) exist in yeast ([@bib62]). To identify which specific sirtuin(s) are connected to the TORC1 pathway, we generated combinatorial mutants of *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* paired with deletions of the individual sirtuins and analyzed global histone acetylation. Each double mutant resulted in a unique array of acetylation changes, but only the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* restored H3K18ac, H3K23ac, and H4K12ac to near WT levels ([Figure 4, E and F](#fig4){ref-type="fig"}). These data are consistent with our previous finding that *[hst3](http://www.yeastgenome.org/locus/S000005551/overview)Δ* or *[hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* restores H3K56ac in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* and suggest that TORC1-dependent regulation of site-specific H3/H4 N-terminal acetylation requires repression of PP6 activity and downstream suppression of sirtuin deacetylases, particularly [Hst4](http://www.yeastgenome.org/locus/S000002599/overview).

TORC1 regulates Hst4 cellular localization and stability {#s13}
--------------------------------------------------------

Recently, inhibition of the mammalian TORC1 (mTORC1) complex was demonstrated to induce transcriptional upregulation of *SIRT4* to promote glutamine anaplerosis ([@bib8]). We next assessed if the [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-dependent decrease in histone acetylation upon TORC1 inhibition could be explained by increased [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) expression. To address this, we integrated a 9xMyc epitope at the *[HST4](http://www.yeastgenome.org/locus/S000002599/overview)* genomic locus in WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* backgrounds, and then cells were either mock treated or treated with MSX or rapamycin for the indicated times. No significant difference in [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) levels was detected in WT cells treated for 20 min with either MSX or rapamycin; however, both *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* and WT cells treated with rapamycin for 60 min displayed increased [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels compared to the mock-treated WT control ([Figure 5A](#fig5){ref-type="fig"} and [Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS3.pdf)). These results were surprising since we previously determined that 20 min of rapamycin or MSX treatment was sufficient to effectively decrease histone acetylation ([Figure 1E](#fig1){ref-type="fig"} and [Figure S1B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS1.pdf)), yet [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels do not increase until much later after TORC1 suppression. We evaluated the other sirtuins in response to TORC1 inhibition and found that only [Sir2](http://www.yeastgenome.org/locus/S000002200/overview) protein was similarly elevated ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS3.pdf)). However, [Sir2](http://www.yeastgenome.org/locus/S000002200/overview) is unlikely to contribute to the decrease in histone acetylation upon TORC1 limitation, since a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sir2](http://www.yeastgenome.org/locus/S000002200/overview)Δ* mutant failed to restore TORC1-responsive histone acetylation ([Figure 4, E and F](#fig4){ref-type="fig"}).

![Sit4 activation due to TORC1 inhibition promotes increased Hst4 protein stability. (A) No tag, WT Hst4-9xMyc and *tco89Δ* Hst4-9xMyc were cultured to log phase and WT-tagged cells were then mock treated or treated with 2 mM MSX (20 min) or 300 nM rapamycin (20 min, 60 min) before harvesting. Extracts were prepared and analyzed by IB as indicated. ImageJ analysis was conducted to determine Hst4 levels relative to G6PDH and the average values are provided. Blots and ImageJ data are representative of at least three independent experiments. (B) No tag, WT Hst4-9xMyc, *sit4Δ* Hst4-9xMyc, *sap4Δ* Hst4-9xMyc, *tco89Δ* Hst4-9xMyc, *sit4Δ tco89Δ* Hst4-9xMyc, and *sap4Δ tco89Δ* Hst4-9xMyc cells were cultured and analyzed as in A. (C) WT, *tco89Δ*, *hst4Δ*, and *tco89Δ hst4Δ* cells were cultured to log phase, total RNA was extracted, cDNA was synthesized, and qPCR performed with the indicated primer sets. Data are the average and SD of four independent experiments, and significance was determined by Student's *t*-test. *\* P* \< 0.05; *\*\* P* \< 0.01; *\*\*\* P* \< 0.001. (D) Strains from B were cultured to log phase and treated with 50 μg/ml CHX. Samples were taken at *T*~0~ prior to CHX addition and then again at *T*~20~ and *T*~45~. Short and long exposures of the α-Myc blot are shown for clarity, and quantification of the data is provided. Data are average and SD of four independent biological replicates and significance was determined as in C. (E) As in D, except Hst3 stability is being measured. Time points differ from D as indicated.](1733fig5){#fig5}

To ascertain whether [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) contributes to the regulation of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein expression, we generated *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* strains in the [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc background and examined [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) levels. While *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* increases [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) expression, the *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* dramatically reduced [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) levels relative to WT ([Figure 5B](#fig5){ref-type="fig"}). Intriguingly, the *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ [tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* returned [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) expression to WT levels, suggesting that TORC1 acts to repress PP6 activity and limit [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein expression ([Figure 5B](#fig5){ref-type="fig"}). When the experiment was repeated in a *[sap4](http://www.yeastgenome.org/locus/S000003198/overview)Δ* background, which is the regulatory subunit that most robustly restored histone acetylation in response to rapamycin ([Figure 3D](#fig3){ref-type="fig"}), we observed a comparably modest effect on [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels ([Figure 5B](#fig5){ref-type="fig"}). These findings are in line with the possibility that some functional redundancy may exist between these PP6 regulatory subunits in relation to [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) regulation. We then confirmed this [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-dependent, TORC1-responsive effect on [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) levels was not due to transcriptional or post-transcriptional changes in *[HST4](http://www.yeastgenome.org/locus/S000002599/overview)* messenger RNA (mRNA) expression by analyzing *[HST4](http://www.yeastgenome.org/locus/S000002599/overview)*, as well as *[HST3](http://www.yeastgenome.org/locus/S000005551/overview)* and *[SIR2](http://www.yeastgenome.org/locus/S000002200/overview)* gene expression by qPCR. Expression of *[HST3](http://www.yeastgenome.org/locus/S000005551/overview) and [HST4](http://www.yeastgenome.org/locus/S000002599/overview)* was not increased in the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* background ([Figure 5C](#fig5){ref-type="fig"}), and while we do detect a minor, but statistically significant decrease in *[SIR2](http://www.yeastgenome.org/locus/S000002200/overview)* mRNA expression in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* relative to WT, its significance is currently unclear.

[Hst3](http://www.yeastgenome.org/locus/S000005551/overview) protein degradation has been previously shown to be cell-cycle regulated through Cdk1-dependent phosphorylation and subsequent SCF^[Cdc4](http://www.yeastgenome.org/locus/S000001885/overview)^-dependent ubiquitination, leading to its proteasome-mediated degradation ([@bib10]; [@bib12]). Whether any phosphatase opposes this Cdk1-dependent phosphorylation remains unknown. [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) was also identified as a candidate SCF^[Cdc4](http://www.yeastgenome.org/locus/S000001885/overview)^ substrate, although control of its turnover has not been examined in detail ([@bib40]). We wondered whether TORC1-dependent regulation of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein expression occurs through altered protein stability. WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* strains expressing [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc were cultured to log phase and then treated with 50 μg/ml CHX to inhibit protein synthesis. As a comparison, we performed an identical experiment with Hst3-9xMyc-expressing cells. Intriguingly, we found that while [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) turnover was reduced in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* compared to WT, [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) degradation was accelerated in the TORC1 mutant ([Figure 5, D and E](#fig5){ref-type="fig"}). In addition we show that in a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc strain, which previously restored WT levels of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) expression compared to a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* alone ([Figure 5B](#fig5){ref-type="fig"}), the rate of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) turnover strongly resembles that detected in WT cells ([Figure 5D](#fig5){ref-type="fig"}). Together, these data demonstrate that TORC1 signaling via the [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) phosphatase complex regulates the proteolytic decay of the sirtuins [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) and [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) in an inverse fashion, such that TORC1 promotes [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) turnover while it stabilizes [Hst3](http://www.yeastgenome.org/locus/S000005551/overview).

Reduced TORC1 signaling and subsequent Sit4 activation promotes Hst4 nuclear accumulation, which precedes the increase in Hst4 protein levels {#s14}
---------------------------------------------------------------------------------------------------------------------------------------------

A subset of metazoan sirtuins have been shown to actively shuttle between the nucleus and the cytoplasm as a function of cell-cycle progression or in response to cellular stress ([@bib60]; [@bib50]; [@bib57]; [@bib21]). [Hst4](http://www.yeastgenome.org/locus/S000002599/overview), which has been proposed to be the yeast SIRT3 ortholog, is normally distributed between the cytoplasm and nucleus. Upon biotin starvation, however, [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) accumulates at mitochondria to facilitate mitochondrial protein deacetylation ([@bib39]). As mentioned previously, the best-characterized role that TORC1 suppression, and consequent [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) activation, has is to induce nuclear localization of transcription factors controlling the NCR pathway ([@bib6]). We therefore considered the possibility that reduced TORC1 signaling might also stabilize [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) by altering its cellular distribution. To test this, WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells expressing either [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc or the other tagged sirtuins, were cultured to log phase before performing α-Myc immunostaining and quantitative confocal microscopy analysis. Random fields of cells were captured and the amount of nuclear sirtuin was manually quantified as described in *Materials and Methods*. Representative images for [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) are shown in [Figure 6A](#fig6){ref-type="fig"} and for all five sirtuins in [Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS4.pdf). Intriguingly, *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* enhanced the [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) nuclear pool, even after accounting for the increase in [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels ([Figure 6, A and B](#fig6){ref-type="fig"}). A minor increase in [Sir2](http://www.yeastgenome.org/locus/S000002200/overview) nuclear accumulation was also detected but none of the other sirtuins, including [Hst3](http://www.yeastgenome.org/locus/S000005551/overview), exhibited a significant change in localization ([Figure 6B](#fig6){ref-type="fig"} and [Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS4.pdf)). To specifically address whether the increase in [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) nuclear localization occurred before or after [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels were increased, we repeated the WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc immunostaining experiment, this time including an additional WT sample treated with 200 nM rapamycin for 20 min. We detected maximal [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) relocalization within 20 min after rapamycin addition, which was approximately equivalent to the amount of nuclear-localized [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) observed in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* ([Figure 6C](#fig6){ref-type="fig"} and [Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS4.pdf)). This relocalization is far earlier than the observed increase in protein levels ([Figure 5A](#fig5){ref-type="fig"}), and it correlates with the decrease in histone acetylation ([Figure S1B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS1.pdf)). Finally, we asked whether this relocalization was dependent on [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) activation downstream of TORC1 inhibition, since [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) regulates [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels ([Figure 5, B and D](#fig5){ref-type="fig"}). Strikingly, we found that in a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-9xMyc strain, the cytoplasmic population of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) is restored to near WT levels ([Figure 6, A and C](#fig6){ref-type="fig"}), supporting the hypothesis that decreased TORC1 signaling triggers [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)/PP6 activation, which promotes [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) nuclear localization and stabilization to mediate site-specific histone deacetylation.

![Hst4 nuclear relocalization occurs rapidly as a consequence of TORC1 inhibition and Sit4 activation, which precedes the increase in Hst4 stability. (A) Representative confocal microscopy of WT, *tco89Δ* Hst4-9xMyc, and *tco89Δ sit4Δ* Hst4-9xMyc expressing cells. Cells without a Myc tag (no tag) are included as an indicator of background fluorescence. (B) Quantification of sirtuin microscopy images, including those shown in A and [Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS4.pdf), was performed as described in *Materials and Methods*. Data represented are the average and SD of four independent experiments and significance was determined by Student's *t*-test. *\* P* \< 0.05; *\*\* P* \< 0.01. (C) As in B, except WT Hst4-9xMyc cells were mock or rapamycin treated (300 nM, 20 min) prior to imaging. *tco89Δ* Hst4-9xMyc and *tco89Δ sit4Δ* Hst4-9xMyc cells are included for comparison.](1733fig6){#fig6}

Hst4-regulated histone acetylation controls a subset of TORC1-dependent biological functions {#s15}
--------------------------------------------------------------------------------------------

TORC1 was identified previously to regulate acetylation of the RP genes through the recruitment of the [Esa1](http://www.yeastgenome.org/locus/S000005770/overview) acetyltransferase ([@bib46]). The initial [Tco89](http://www.yeastgenome.org/locus/S000006101/overview) characterization conducted by [@bib45] determined *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* has no effect on RP gene transcription. Given the observed acetylation defects in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ*, we chose to independently determine whether reduced TORC1 signaling may alter RP gene expression through an [Hst4](http://www.yeastgenome.org/locus/S000002599/overview)-dependent mechanism. Similar to the findings reported by [@bib45], we found that although TORC1 activity is reduced in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* ([Figure S1A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.188458/-/DC1/FigureS1.pdf)), no significant decrease in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* RP gene expression occurred ([Figure 7A](#fig7){ref-type="fig"}). Additionally, the *[hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* had no effect on RP gene expression, and while *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* modestly reduced expression of *[RPL23B](http://www.yeastgenome.org/locus/S000000919/overview)*, *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* did not affect the expression of the other RP genes ([Figure 7A](#fig7){ref-type="fig"}). These data indicate that the residual TORC1 activity retained in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* is sufficient to maintain normal RP gene expression and that [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) does not significantly contribute to their regulation.

![TORC1-mediated histone acetylation does not impact RP gene transcription but is involved in the DNA-damage response and cell-cycle progression. (A) WT, *tco89Δ*, *hst4Δ*, and *tco89Δ hst4Δ* cells were cultured to log phase, total RNA was extracted, cDNA was synthesized, and qPCR performed with the indicated primer sets. Data are the average and SD of three independent experiments and significance was determined by Student's *t*-test. (B) WT, *tco89Δ*, *hst3Δ*, *tco89Δ hst3Δ*, *hst4Δ*, *tco89Δ hst4Δ*, *sit4Δ*, and *tco89Δ sit4Δ* were cultured overnight to saturation. Equal numbers of cells were serially diluted fivefold and spotted onto YPD, YPD 5 nM rapamycin, YPD 10 nM rapamycin, YPD 100 mM hydroxyurea (HU), and YPD 1 mM arsenic oxide (AsO~3~). Images were taken 4 days after spotting.](1733fig7){#fig7}

Previous studies demonstrated that exposure to nutrient starvation or rapamycin treatment causes *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells to exit the cell cycle and enter into an irreversible, *G*~0~-like growth arrested state ([@bib2]). We next asked whether restoration of TORC1-mediated histone acetylation could rescue the sensitivity of *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* mutants to multiple conditions that impair TORC1 signaling ([@bib23]; [@bib31]). We found this effect was reversed in a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* mutant, and to a lesser extent in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [hst3](http://www.yeastgenome.org/locus/S000005551/overview)Δ*, under low (5 nM) rapamycin concentrations ([Figure 7B](#fig7){ref-type="fig"}). Surprisingly, at slightly higher (10 nM) rapamycin concentrations, neither double mutant grew significantly ([Figure 7B](#fig7){ref-type="fig"}). Intriguingly, the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ [sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* failed to restore growth in the presence of even the low rapamycin concentration; however, combining *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* with either *[hst3](http://www.yeastgenome.org/locus/S000005551/overview)Δ*, *[hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ*, or *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* completely restored growth on both hydroxyurea and arsenic ([Figure 7B](#fig7){ref-type="fig"}). These results demonstrate that sirtuins are important for maintaining the *G*~0~-like growth-arrested state that TORC1 mutants exhibit when exposed to environmental stressors that inhibit TORC1 activity. However, while [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) loss can rescue this growth arrest in the presence of some TORC1 inhibitors, it appears to have functions independent of its link to sirtuins that are required for TORC1 impaired cells to escape the growth arrest induced specifically by rapamycin.

Discussion {#s16}
==========

The epigenome of eukaryotic cells is responsive to environmental stimuli, including changes in nutrient availability. Previous studies have shown that TORC1 signaling affects epigenetic processes, including mediating [Esa1](http://www.yeastgenome.org/locus/S000005770/overview) recruitment to RP genes to acetylate histone H4, as well as regulating global H3K56ac ([@bib46]; [@bib5]). In this report, we significantly expand our understanding of the mechanistic link between TORC1 signaling and its downstream effects on site-specific histone acetylation modifications. We demonstrate for the first time that in logarithmically growing cells, TORC1 inhibition results in a rapid, direct, and selective deacetylation of H3K18, H3K23, and H4K12 on the histone H3/H4 N termini. To date, studies examining TORC1-regulated acetylation have used the TORC1 inhibitor rapamycin to examine the functional consequences TORC1 activity has on chromatin ([@bib46]; [@bib18]; [@bib5]). And while we also utilized rapamycin for this purpose, we extended our analyses to include other methods to suppress TORC1, including subunit deletion (*[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ*) and a pharmacological inhibitor of nitrogen metabolism (MSX) ([@bib7]). We provide clear evidence that either of these additional conditions are sufficient to decrease site-specific histone H3/H4 acetylation, thus implicating nitrogen-dependent TORC1 activation as a significant regulator of histone acetylation.

Previous studies demonstrated that stationary phase cells exhibit reduced histone acetylation at many of the same residues identified above ([@bib14]). These acetylation states were rescued by glucose refeeding, suggesting that carbon metabolism is a significant regulator of these histone modifications. However, we find that culturing WT and *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* cells in media containing either a preferred, fermentable (glucose) carbon or a nonpreferred, nonfermentable (glycerol) carbon source, resulted in no change to the spectrum of observed histone acetylation defects. Our data argue against the possibility that crosstalk between carbon metabolism and TORC1 regulation, as was previously suggested, is ultimately responsible for the chromatin effects we observe ([@bib51]; [@bib9]). Instead, our findings suggest that in actively growing cells, nitrogen signaling through TORC1 is the predominant regulator of these specific histone acetylation states. As a consequence, the vacuole likely serves a vital link in the transmission of environmental nutrient sufficiency to the epigenetic regulatory apparatus via TORC1 activation. Indeed, a previous genetic screen of the systematic yeast deletion collection identified several vacuole mutants, including many V-ATPase mutants, to be necessary for maintenance of global histone acetylation ([@bib43]).

Our study also provides a more detailed mechanistic understanding of our previous work, which identified a functional relationship between TORC1, sirtuins, and the regulation of H3K56ac. We demonstrate by direct pharmacological inhibition, cofactor depletion, and individual sirtuin deletion that TORC1 signaling specifically opposes histone deacetylation mediated by several sirtuin family members. Importantly, [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) was the only sirtuin that, when deleted in a *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* background, restored acetylation across all of the known TORC1-regulated residues. This suggests that while TORC1 may have a general role in opposing sirtuin activity, [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) is likely to be one of the predominant sirtuins whose function is negatively affected by signaling through this pathway. The intimate link between TORC1 and the sirtuins is interesting, considering that both are responsive to cellular energetics, albeit inversely. This relationship appears to be conserved at some level across all eukaryotes ([@bib18]; [@bib5]; [@bib8]; [@bib28]). Together, our data support a model whereby TORC1 and sirtuin activity are regulated in an opposing manner to coordinate both nitrogen and energy metabolism with epigenetic control to facilitate productive cell growth and proliferation.

The presented findings also implicate TORC1-dependent suppression of the [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-associated [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) containing PP6 phosphatase complex in the regulation of histone acetylation. We demonstrate that these effects are independent of changes in *[HST4](http://www.yeastgenome.org/locus/S000002599/overview)* gene expression, and that [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-regulated histone acetylation suppression is separable from [Sit4](http://www.yeastgenome.org/locus/S000002205/overview)-dependent activation of the NCR pathway. Instead, we provide support for a mechanism in which [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) activation promotes both a rapid cytoplasmic-to-nuclear redistribution of [Hst4](http://www.yeastgenome.org/locus/S000002599/overview), and an eventual increase in [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein levels due to reduced protein turnover. Considering that maximal [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) relocalization occurs within 20 min post-TORC1 inhibition, but [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) protein does not accumulate significantly until ∼40 min later, [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) movement to the nucleus may function to shield a fraction of the enzyme from proteolytic turnover. These effects on [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) are unique, as identical experiments with a highly similar sirtuin, [Hst3](http://www.yeastgenome.org/locus/S000005551/overview), revealed that lower TORC1 activity does not affect [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) nuclear localization but does decrease [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) protein stability. How TORC1-dependent suppression of the [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) phosphatase causes these opposing effects on [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) and [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) stability is the subject of ongoing investigation. A distinct possibility is that changes in nutrient sufficiency modify TORC1-regulated [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) activity to affect [Hst3](http://www.yeastgenome.org/locus/S000005551/overview) and [Hst4](http://www.yeastgenome.org/locus/S000002599/overview) phosphorylation status and regulate their SCF^[Cdc4](http://www.yeastgenome.org/locus/S000001885/overview)^-dependent turnover. Such a regulatory mechanism might better coordinate the cellular growth response with cell division timing, as all of these factors are also intimately connected to cell-cycle regulation.

Histone acetylation regulates gene expression, in part, by disrupting histone--DNA contacts to promote chromatin decondensation, as well as by serving as docking sites for bromodomain- or YEATS-domain-containing regulatory factors ([@bib49]; [@bib52]). While TORC1 signaling is known to regulate the transcription of a large number of genes involved in cell growth and proliferation, the functional contributions our newly characterized TORC1-regulated histone acetylation states have in relation to these processes are currently unclear. In agreement with a previous report ([@bib45]), we find that in the *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* TORC1 mutant, RP gene expression is largely unaffected. We believe this demonstrates that there is sufficient residual TORC1 activity present in these mutants to maintain basal [Sch9](http://www.yeastgenome.org/locus/S000001248/overview) activation and RP gene expression. However, TORC1 transcriptional regulation extends beyond just RP genes, so it is likely that other genes will be preferentially sensitive to the reduced histone acetylation we have detected. Identifying which acetyl lysine binding proteins are affected by altered TORC1 signaling will be critical to completely define how TORC1-dependent histone acetylation contributes to transcriptional programs controlling growth and proliferation.

Cells deficient in TORC1, such as *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* mutants, are acutely sensitive to environmental exposures that suppress TORC1 signaling, including rapamycin, DNA replication inhibitors, metals, and a variety of other stress-inducing agents. And while these compounds are often grouped together as having a generalized inhibitory effect on TORC1, the downstream cellular responses they elicit can vary substantially ([@bib58]; [@bib26]). We demonstrate that the TORC1--PP6--sirtuin pathway outlined above is functionally relevant for a subset of TORC1-regulated biological processes, as either *[hst3](http://www.yeastgenome.org/locus/S000005551/overview)Δ* or *[hst4](http://www.yeastgenome.org/locus/S000002599/overview)Δ* can suppress *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* sensitivity to arsenic, hydroxyurea, and low concentrations of rapamycin. We believe that these sirtuins may contribute to enforcing the cell-cycle exit that occurs in *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* exposed to TORC1 suppressive conditions, in part through their role in chromatin deacetylation. Loss of either sirtuin may facilitate cell-cycle reentry following TORC1 inhibition by maintaining a more basally hyperacetylated, transcriptionally permissive chromatin state, thus allowing for more facile induction of genes necessary to escape the arrested state. The recent identification of a glucose-regulated histone acetylation pathway necessary for transcription of the *[CLN3](http://www.yeastgenome.org/locus/S000000038/overview)* cyclin, and subsequent entry into the cell cycle, provides support for this concept ([@bib53]).

Furthermore, we demonstrate that while *[sit4](http://www.yeastgenome.org/locus/S000002205/overview)Δ* also rescues the sensitivity of *[tco89](http://www.yeastgenome.org/locus/S000006101/overview)Δ* to both hydroxyurea and arsenic, it fails to promote growth on rapamycin. These results suggest the possibility that [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) has sirtuin-independent roles in regulating cell growth control that are necessary for TORC1-deficient cells to escape the rapamycin-induced growth arrest ([@bib55]; [@bib13]). There is a precedent for [Tap42](http://www.yeastgenome.org/locus/S000004630/overview)-associated phosphatases regulating such dynamics as it was previously shown that the nitrogen-responsive [Rim15](http://www.yeastgenome.org/locus/S000001861/overview)-dependent phosphorylation of PP2A phosphatase plays a critical role in cell-cycle entry, as well as exit from quiescence ([@bib3]). Another candidate explanation is that [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) association with distinct Sap regulatory factors may have context-specific effects. In support of this, a previous report determined that the function [Sit4](http://www.yeastgenome.org/locus/S000002205/overview) has in response to TORC1 suppression depends on the identity of the associated Sap regulator ([@bib47]). Unraveling these differences, and their specific role in sirtuin regulation, will be the subject of future studies.

Overall, our data define a mechanism by which nitrogen signaling through TORC1 activation controls specific epigenetic modifications that are important for TORC1-regulated cell growth and proliferation. Because these pathways are conserved in mammals, we consider it highly likely that deregulation of nitrogen metabolism and aberrant mTORC1 activation, which occurs in many cancers, might alter the epigenome through similar mechanisms to promote disease pathogenesis.
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